ArticleMolecular biology reports2025
"Circulating MiRNAs targeting antioxidant genes: potential biomarkers for type 2 diabetes mellitus".
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEpigenetic factors, especially microRNAs (miRNAs), are gaining attention as promising biomarkers for disease prediction, detection, and monitoring. Variations in circulating miRNA levels have been linked to pre-diabetes, diabetes, and associated complications, showing their potential as early indicators of disease. The aim of the present study is to investigate the potential of hsa-miR-377-3p, hsa-miR-513a-3p, and hsa-miR-30b-5p as early biomarkers for identifying people at risk of type 2 diabetes (T2DM) and to look into how they contribute to the pathophysiology of the disease. METHODS AND
resultsThe current case-control study involved 104 participants, categorized into pre-diabetic (N = 20), diabetic (N = 40), and healthy controls (N = 44), recruited from King Georges’ Medical University, India. Proper ethical approval and informed consent were obtained. Participants were assessed based on fasting plasma glucose (FPG) and glycated haemoglobin (HbA1c) levels. Serum samples were collected for biochemical analysis and miRNA isolation. The expression of particular miRNAs related to antioxidant pathways was investigated using quantitative real-time PCR. Significant differences were observed in clinical parameters among the study groups. Diabetic individuals exhibited elevated FPG and HbA1c levels compared to pre-diabetics and controls. Notably, miRNAs viz. hsa-miR-377-3p, hsa-miR-513a-3p, and hsa-miR-30b-5p were identified as potential biomarkers linked to T2DM pathogenesis and antioxidant regulation. The study highlighted the role of these miRNAs in the development of diabetes-related complications and their potential as therapeutic targets.
conclusionsThe findings exhibited the necessity for early identification of individuals at risk for T2DM through miRNA profiling. This study contributes in the development of innovative diagnostic and treatment approaches as well as the comprehension of the molecular mechanisms underlying T2DM.
Indexed as
Identifiers
40580334What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.